Page 325 - 20dynamics of cancer
P. 325

310                                                CHAPTER 15

                              quantitative analysis that can be molded to the data. Second, simple
                              comparative hypotheses create the back and forth loop between predic-
                              tions and tests that reveal causality.
                                Breast cancer illustrates the importance of breadth in analysis. Breast
                              cancer incidence rises rapidly through midlife and rises slowly after
                              menopause (Figures A.1, A.2); ovarian cancer follows a similar pattern
                              (Figures A.7, A.8). The rate of cell division in female reproductive tis-
                              sues declines after menopause. It seems natural to relate cell division to
                              incidence, because the rate of mitosis sets one of the major risk factors
                              in cancer. So we may easily fit a model in which mitotic rate shapes the
                              incidence pattern of breast and ovarian cancer.
                                My broad synthesis of pattern and process in cancer quickly shows
                              how little we learn from the fit of the mitotic rate model to breast and
                              ovarian cancer incidence. On the pattern side, breast and ovarian cancer
                              incidence do follow changes in reproductive status, but so do cancers
                              of the kidney, esophagus, and larynx in both males and females (Fig-
                              ures A.7, A.8).
                                The broad look at pattern in the Appendix shows that many cancers
                              have rising incidence through midlife followed by a tendency of the inci-
                              dence curve to flatten (declining acceleration). This common incidence
                              trend of many cancers suggests a universal process.
                                What sort of universal process might explain declining acceleration
                              later in life? In my theory chapters, I developed a broad conceptual
                              framework for how various processes of progression affect incidence.
                              That broad framework showed that many different processes cause de-
                              clining acceleration with age.
                                My favored explanation follows from a universal aspect of multistage
                              progression: as individuals age, they progress stochastically through
                              the early stages of disease. Later in life, they have fewer steps remaining
                              to overt symptoms. With fewer stages remaining, incidence accelerates
                              more slowly with age. This progression scenario fits the data. But I also
                              showed that environmental or genetic heterogeneity can fit the patterns
                              of declining acceleration. By looking broadly at the theory, we avoid
                              latching onto the first good fit.
                                The theory leaves us with alternative plausible hypotheses, which is
                              all that we should expect from a quantitative framework. But with so
                              many alternatives, some might feel that it is too hard to match biochem-
   320   321   322   323   324   325   326   327   328   329   330